Long Term Follow-Up of First Generation versus New Generation Drug-Eluting Stents in Three-Vessel Coronary Artery Disease
Backgrounds.Few reports have primarily focused on long-term clinical outcomes in three-vessel disease when patients were treated with either first- or new-generation drug-eluting stents (DES).The purpose of this study was to investigate different clinical outcomes after percutaneous coronary intervention (PCI) for three-vessel disease with first- or new-generation DES.
Source: Cardiovascular Revascularization Medicine - Category: Cardiology Authors: Toru Yoshizaki, Toru Naganuma, Tsuyoshi Kobayashi, Takeo Horikoshi, Hirokazu Onishi, Hiroyoshi Kawamoto, Shotaro Nakamura, Sunao Nakamura Source Type: research
More News: Angioplasty | Cardiology | Cardiovascular | Coronary Angioplasty | Heart | Percutaneous Coronary Intervention | Study